{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:46:35Z","timestamp":1787676395628,"version":"build-2784847793"},"reference-count":30,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol Myers Squibb\/Pfizer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) and clinical atrial fibrillation are closely linked, but the relationship between device-detected subclinical atrial fibrillation (SCAF) and HF is unclear. We aimed to determine incidence and clinical risk factors for HF events among patients with SCAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 3986 patients from the ARTESiA (Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation) trial. ARTESiA investigated the effect of apixaban versus aspirin for stroke prevention in patients with episodes of SCAF \u226424 hours. In this secondary analysis, we explored the number and duration of SCAF episodes at baseline as risk markers for HF hospitalization or HF-related death. SCAF progression was analysed as a time-dependent covariate and defined as the development of SCAF &amp;gt;24 hours or clinical atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a mean follow-up of 4.1 \u00b1 1.7 years, SCAF progression was observed in 1244 patients (31%). Heart failure hospitalization or HF-related death occurred in 515 (13%) patients at a rate of 3.3 [95% confidence interval (CI) 3.1-3.6] per 100 person-years. A total of 172 HF-related events occurred after SCAF progression (7.2 events, 95% CI 6.2-8.3, per 100 PY). SCAF progression was an independent risk factor for HF hospitalization or HF-related death (hazard ratio 2.72, 95% CI 2.24-3.31).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Heart failure hospitalization and HF-related death are common in patients with SCAF. Progression to longer SCAF episodes or clinical AF were associated with HF events, but episodes &amp;lt;24\u2005h were not. These findings underscore the need for close surveillance of SCAF patients to detect complications and potentially improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejhf\/xuag022","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:19:19Z","timestamp":1768825159000},"source":"Crossref","is-referenced-by-count":1,"title":["Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-1032","authenticated-orcid":false,"given":"Maria Hee Jung Park","family":"Frausing","sequence":"first","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Palle Juul-Jensens Bvld. 99, Aarhus N DK-8200 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Palle-Juul Jensens Bvld. 11, Aarhus N DK-8200 ,","place":["Denmark"]},{"name":"Department of Cardiology, Hospitalsenhed Midt , Banevejen 7C, Viborg DK-8800 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S","family":"Healey","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Kovalova","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A","family":"Wong","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-0857","authenticated-orcid":false,"given":"S\u00f8ren Z\u00f6ga","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Yixi","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen ,","place":["Denmark"]},{"name":"Department of Internal Medicine, Zealand University Hospital\u2014Nyk\u00f8bing Falster , Nyk\u00f8bing Falster ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B","family":"Granger","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D","family":"Lopes","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P","family":"Benz","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia W","family":"Erath","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Goethe University, University Hospital Frankfurt , Frankfurt am Main ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mabo","sequence":"additional","affiliation":[{"name":"Cardiologie et Maladies Vasculaire, Centre Hospitalier Universitaire , Rennes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-6023","authenticated-orcid":false,"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[{"name":"Karolinska Institutet and the Heart, Vascular, and Neurology Theme, Karolinska University Hospital and Karollinska Institutet Stockholm , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Liverpool Heart and Chest Hospital , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-289X","authenticated-orcid":false,"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology Division, University of Rochester Medical Center , Rochester, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Birnie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Cardiology, University of Ottawa Heart Institute , Ottawa, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-8901","authenticated-orcid":false,"given":"Juan","family":"Benezet-Mazuecos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario La Luz , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi E","family":"Albertsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Viborg Regional Hospital , Viborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja Fiedler","family":"Holm","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aalborg University Hospital , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G","family":"Andrade","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Cardiac Surgery, Vancouver General Hospital , Vancouver, BC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-1653","authenticated-orcid":false,"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Palle Juul-Jensens Bvld. 99, Aarhus N DK-8200 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Palle-Juul Jensens Bvld. 11, Aarhus N DK-8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2026041313511974300_xuag022-B1","doi-asserted-by":"publisher","first-page":"e030438","DOI":"10.1161\/JAHA.123.030438","article-title":"Global burden of atrial fibrillation and flutter by national income: results from the Global Burden of Disease 2019 Database","volume":"12","author":"Ohlrogge","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026041313511974300_xuag022-B2","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2026041313511974300_xuag022-B3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026041313511974300_xuag022-B4","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1093\/eurheartj\/ehae596","article-title":"Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"45","author":"Schnabel","year":"2024","journal-title":"Eur Heart J"},{"key":"2026041313511974300_xuag022-B5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026041313511974300_xuag022-B6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026041313511974300_xuag022-B7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2023","journal-title":"N Engl J Med"},{"key":"2026041313511974300_xuag022-B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","article-title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","volume":"189","author":"Lopes","year":"2017","journal-title":"Am Heart J"},{"key":"2026041313511974300_xuag022-B9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.124.069903","article-title":"Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"150","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"2026041313511974300_xuag022-B10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"2026041313511974300_xuag022-B11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"2026041313511974300_xuag022-B12","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology council on stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2026041313511974300_xuag022-B13","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1016\/j.hrthm.2025.07.002","article-title":"Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"22","author":"Boriani","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026041313511974300_xuag022-B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jacc.2024.05.002","article-title":"Apixaban vs aspirin according to CHA(2)DS(2)-VASc score in subclinical atrial fibrillation: insights from ARTESiA","volume":"84","author":"Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026041313511974300_xuag022-B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jchf.2016.09.016","article-title":"Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation","volume":"5","author":"Pandey","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026041313511974300_xuag022-B16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/eurjhf\/hft004","article-title":"Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study","volume":"15","author":"Potpara","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026041313511974300_xuag022-B17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/eurjhf\/hft041","article-title":"Risk assessment for incident heart failure in individuals with atrial fibrillation","volume":"15","author":"Schnabel","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026041313511974300_xuag022-B18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/eurheartj\/ehi694","article-title":"Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades","volume":"27","author":"Miyasaka","year":"2006","journal-title":"Eur Heart J"},{"key":"2026041313511974300_xuag022-B19","doi-asserted-by":"publisher","first-page":"e012764","DOI":"10.1161\/CIRCEP.124.012764","article-title":"Heart failure events after long-term continuous screening for atrial fibrillation: results from the randomized LOOP study","volume":"17","author":"Xing","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026041313511974300_xuag022-B20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jacc.2010.08.624","article-title":"Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators","volume":"57","author":"Santini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026041313511974300_xuag022-B21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2020.03.008","article-title":"Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction","volume":"312","author":"Zakeri","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026041313511974300_xuag022-B22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jacep.2021.09.015","article-title":"Temporal association of atrial fibrillation with cardiac implanted electronic device detected heart failure Status","volume":"8","author":"Capucci","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2026041313511974300_xuag022-B23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jchf.2016.12.011","article-title":"A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study","volume":"5","author":"Boehmer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026041313511974300_xuag022-B24","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from The Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026041313511974300_xuag022-B25","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA). of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"2026041313511974300_xuag022-B26","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026041313511974300_xuag022-B27","doi-asserted-by":"publisher","first-page":"e019168","DOI":"10.1161\/JAHA.120.019168","article-title":"Biomarkers of inflammation and risk of hospitalization for heart failure in patients with atrial fibrillation","volume":"10","author":"Benz","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026041313511974300_xuag022-B28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2026041313511974300_xuag022-B29","doi-asserted-by":"publisher","first-page":"euad051","DOI":"10.1093\/europace\/euad051","article-title":"Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial","volume":"25","author":"Gottschalk","year":"2023","journal-title":"Europace"},{"key":"2026041313511974300_xuag022-B30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jchf.2023.09.023","article-title":"Prevalence of subclinical atrial fibrillation in heart failure with preserved ejection fraction","volume":"12","author":"Yang","year":"2024","journal-title":"JACC Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag022\/66817725\/xuag022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag022\/66817725\/xuag022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:51:31Z","timestamp":1776102691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag022\/8468894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag022","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"xuag022"}}